Healthcare+ Data-driven drug development: applied AIThe EPO’s requirements for sufficiency in applied AI and machine learning inventionsRead More 21Mar2024 Decision making at the UPC: MedTechFor Medtech companies dealing with a patchwork of European rights, the UPC may prove useful for cost-efficiency and speed, alone or alongside traditional defensive and enforcement strategiesRead More 22Nov2023 Data-driven drug development: in silico dataUsing data derived from AI to support life sciences patentsRead More 16Nov2023 Decision making at the UPC: Robotics & SoftwareThe UPC’s tools for information gathering to obtain evidence of infringement under certain jurisdictions may prove to be particularly useful in the robotics and software sectorRead More 27Oct2023 The proposed new SPC regulations – what are stakeholders saying?Support for centralisation but pre-grant opposition unpopularRead More 16Oct2023 Enlarged Board of Appeal delivers decisions on formal priority entitlementThe EPO Enlarged Board of Appeal has held that the applicant benefits from a rebuttable presumption under the EPC that the applicant claiming priority is entitled to claim priorityRead More 10Oct2023 Decision making at the UPC: Life sciences sectorCompanies in the life sciences sector show a healthy appetite to engage with the new court system as the Unified Patent Court opens its doors and Unitary Patents begin to grant – is it time for more companies to join them?Read More 06Oct2023 First inter partes preliminary injunction issued by UPCDecision in spatial imaging field handed down yesterday – decision in related case to followRead More 20Sep2023 Carpmaels engages with EPO consultation on Rules of Procedure of Boards of AppealThe EPO is proposing revisions to the Rules of Procedure of the Boards of Appeal, but the changes could place undue time pressure on partiesRead More 19Sep2023 Will the UPC’s first inter partes preliminary injunction be in the gene sequencing technology field?In this week's PI hearing, 10x Genomics v NanoString Technologies, the criteria behind a UPC injunction were debatedRead More 06Sep2023<12345> Type Firm News Insights PodcastsServiceProtectDealDisputeUPCSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026AugustJulyJuneMayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
